Growth Hormone and Liver Fat Metabolism Study

We are investigating how growth hormone influences fat processing in the liver of healthy adults. Additionally, we will explore its effects in patients with acromegaly to understand fat secretion better.

≤3 months Efficacy phase (II)No Placebo Standard Medicines InjectionEndocrinologyHepatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Genotropin

Genotropin is a medicine that replaces growth hormone to help children and adults with growth problems grow and develop.

Somavert

Somavert is a medicine used to treat acromegaly, a condition caused by excess growth hormone.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Pegvisomant

Pegvisomant is a substance that blocks growth hormone effects to reduce excessive growth in people with acromegaly.

Somatropin

Somatropin is a growth hormone substance used to promote growth and normal body development in people with growth hormone deficiency.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Genotonorm

Genotonorm Kabipen

Genotonorm Miniquick

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Medical University Of Vienna

Department of Medicine III, Division of Endocrinology and Metabolism

Vienna, Austria

Sponsor: Medical University Of Vienna

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.